These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 3502197)
41. [T-lymphocyte subpopulations in autoimmune and subacute thyroiditis treated with T-activin]. Sakaeva NA; Balabolkin MI; Tabagari DZ Sov Med; 1989; (10):39-41. PubMed ID: 2617340 [TBL] [Abstract][Full Text] [Related]
42. [Effectiveness of using immunomodulators in combined treatment of patients with chronic gastritis and ulcer disease]. Arutiunian VM; Grigorian EG Klin Med (Mosk); 2003; 81(5):33-5. PubMed ID: 12856566 [TBL] [Abstract][Full Text] [Related]
43. [Current aspects of the therapy of chronic hepatitis (a review of the literature)]. Cherednichenko TV Vopr Okhr Materin Det; 1979 Nov; 24(11):43-8. PubMed ID: 388858 [No Abstract] [Full Text] [Related]
44. [Cataract extraction in a patient with sympathetic uveitis after immunity correcting therapy]. Tsvetkov AL; Filippova SV; Radzivil TT Vestn Oftalmol; 1998; 114(1):51-2. PubMed ID: 9584644 [TBL] [Abstract][Full Text] [Related]
45. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases]. Iakhontova OI; Dudanova OP; Khavinson VKh Sov Med; 1990; (6):85-8. PubMed ID: 2396134 [No Abstract] [Full Text] [Related]
46. [The use of lithium carbonate in treating patients with diffuse toxic goiter]. Balabolkin MI; Petunina NA; Tsaguriia KG Klin Med (Mosk); 1990 Oct; 68(10):68-9. PubMed ID: 1706446 [No Abstract] [Full Text] [Related]
47. [Clinico-immunological evaluation of using T-activin in children with obstructive bronchitis (data of immediate and late studies)]. Eiubova AA; Budagov FG; Rzakulieva DM Pediatriia; 1991; (1):108. PubMed ID: 2041682 [No Abstract] [Full Text] [Related]
48. [Effect of thymus preparations and anti-tuberculosis agents on immunologic reactivity and the course of the tuberculosis process in experimental animals]. Demidov SV; Miasnikov VG; Chernushenko EF; Osipova LS Probl Tuberk; 1991; (12):52-4. PubMed ID: 1803376 [TBL] [Abstract][Full Text] [Related]
49. [T-activin in multimodal treatment of systemic lupus erythematosus in children]. Kartasheva VI; Tarasova LR; Zaĭrat'iants OV; Belokrinitskiĭ DV Pediatriia; 1991; (3):47-52. PubMed ID: 2047179 [TBL] [Abstract][Full Text] [Related]
50. [Stage-by-stage complex immunologic correction in patients with bronchial asthma living in a large industrial and power plant region]. Grigor'ev MA; Mikhaĭlenko AA; Mel'kova TP Gig Tr Prof Zabol; 1989; (4):25-7. PubMed ID: 2744567 [TBL] [Abstract][Full Text] [Related]
51. [Use of levamisole, an immune controlling agent in various clinical conditions mainly liver diseases (author's transl)]. Miyake M Fukuoka Igaku Zasshi; 1981 Jun; 72(6):368-78. PubMed ID: 6975743 [No Abstract] [Full Text] [Related]
52. [The role of neutrophils in the pathogenesis of psoriasis and the effect of T-activin on them]. Korotkiĭ NG; Udzhukhu VIu; Vasil'eva LL; Redchenko EB; Bagandov TI Vestn Dermatol Venerol; 1987; (7):19-22. PubMed ID: 3673241 [No Abstract] [Full Text] [Related]
53. [Endovascular surgery and the validation of immunocorrection in patients with liver cirrhosis complicated by portal hypertension]. Karimov ShI; Kim VF; Iunusov IR Vestn Khir Im I I Grek; 1991 May; 146(5):26-8. PubMed ID: 1668432 [TBL] [Abstract][Full Text] [Related]
54. [Use of T-activin and thymalin in the treatment of ophthalmic herpes]. Mal'khanov VB; Gripas' IA; Nasibullina GKh; Belousova MA Vestn Oftalmol; 1991; 107(5):51-4. PubMed ID: 1763455 [TBL] [Abstract][Full Text] [Related]
55. [Comparative characteristics of immunomodulators in the combined treatment of patients with mandibular fractures]. Zuev VP; Evglevskaia IuP; Tikhonova GB Stomatologiia (Mosk); 1985; 64(2):34-6. PubMed ID: 3873727 [No Abstract] [Full Text] [Related]
56. [Effect of T-activin and irradiation with a helium-neon laser on the status of the interleukin-2-dependent component of the proliferative response of mononuclear cells in rheumatoid arthritis]. Parnes EIa; Alikhanov BA; Tkomachev IuK; Muromtsev AV Fiziol Cheloveka; 1995; 21(4):143-9. PubMed ID: 7589960 [No Abstract] [Full Text] [Related]
57. [Immunity of middle age and aged patients with tuberculosis and its changes during multimodality treatment by using T-activin]. Adambekov DA; Litvinov VI; Mambetov KB; Koshmuratov AG; Sabyrbekova TS Probl Tuberk; 1998; (5):46-8. PubMed ID: 9866400 [TBL] [Abstract][Full Text] [Related]
58. [Immunologic reactions in patients with diffuse toxic goiter after mercasolyl treatment]. Epishin AV Klin Med (Mosk); 1984 Aug; 62(8):90-3. PubMed ID: 6333549 [No Abstract] [Full Text] [Related]
59. [The use of immunological indices for assessing the severity of the course of periodontitis and treatment efficacy]. Bazhanov NN; Ter-Asaturov GP; Kassin VIu; Ivaniushko TP; Arion VIa; Simonova AV Stomatologiia (Mosk); 1996; 75(1):15-8. PubMed ID: 8658566 [TBL] [Abstract][Full Text] [Related]
60. [The effect of combined therapy with the use of thymalin and piracetam on the level of middle-molecule peptides in the blood and on the lipid peroxidation activity in patients with diffuse toxic goiter]. Iangolenko VV Ter Arkh; 1991; 63(10):60-3. PubMed ID: 1725225 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]